Prestige Consumer Healthcare Inc.
PBH · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.74 | -4.20 | -1.19 | 1.34 |
| FCF Yield | 1.81% | 1.98% | 1.37% | 1.64% |
| EV / EBITDA | 45.85 | 60.94 | 56.74 | 49.24 |
| Quality | ||||
| ROIC | 1.47% | 1.66% | 1.81% | 2.17% |
| Gross Margin | 56.21% | 54.16% | 59.21% | 55.47% |
| Cash Conversion Ratio | 1.36 | 1.66 | 1.23 | 1.07 |
| Growth | ||||
| Revenue 3-Year CAGR | -0.48% | -0.29% | 0.30% | 0.28% |
| Free Cash Flow Growth | -29.15% | 33.93% | -8.12% | -6.27% |
| Safety | ||||
| Net Debt / EBITDA | 10.62 | 11.34 | 10.29 | 9.91 |
| Interest Coverage | 7.94 | 7.03 | 8.22 | 8.03 |
| Efficiency | ||||
| Inventory Turnover | 0.76 | 0.75 | 0.82 | 0.85 |
| Cash Conversion Cycle | 153.11 | 163.75 | 154.68 | 143.76 |